company background image
HCT

Holista CollTechASX:HCT Stock Report

Market Cap

AU$16.2m

7D

0%

1Y

-35.6%

Updated

26 Oct, 2021

Data

Company Financials
HCT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

HCT Overview

Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States.

Price History & Performance

Summary of all time highs, changes and price drops for Holista CollTech
Historical stock prices
Current Share PriceAU$0.058
52 Week HighAU$0.048
52 Week LowAU$0.095
Beta-1.26
1 Month Change-7.94%
3 Month Change-1.70%
1 Year Change-35.56%
3 Year Change-17.14%
5 Year Change-58.57%
Change since IPO-55.39%

Recent News & Updates

Shareholder Returns

HCTAU Personal ProductsAU Market
7D0%-0.5%0.8%
1Y-35.6%22.4%24.4%

Return vs Industry: HCT underperformed the Australian Personal Products industry which returned 22.4% over the past year.

Return vs Market: HCT underperformed the Australian Market which returned 24.4% over the past year.

Price Volatility

Is HCT's price volatile compared to industry and market?
HCT volatility
HCT Beta-1.26
Industry Beta0.70
Market Beta1

Stable Share Price: HCT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: HCT's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aRajen Manickavasagarhttps://www.holistaco.com

Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; and healthy food ingredients, including low-glycaemic index (GI) flour mix for noodles, pasta, flatbreads and other baked products, low-sodium salt, low-fat fried foods, less-calorie sugar, and low-GI sugar.

Holista CollTech Fundamentals Summary

How do Holista CollTech's earnings and revenue compare to its market cap?
HCT fundamental statistics
Market CapAU$16.25m
Earnings (TTM)-AU$1.24m
Revenue (TTM)AU$8.17m

2.0x

P/S Ratio

-12.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HCT income statement (TTM)
RevenueAU$8.17m
Cost of RevenueAU$3.49m
Gross ProfitAU$4.67m
ExpensesAU$5.91m
Earnings-AU$1.24m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0045
Gross Margin57.22%
Net Profit Margin-15.14%
Debt/Equity Ratio17.6%

How did HCT perform over the long term?

See historical performance and comparison

Valuation

Is Holista CollTech undervalued compared to its fair value and its price relative to the market?

3.62x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate HCT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate HCT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: HCT is unprofitable, so we can't compare its PE Ratio to the Global Personal Products industry average.

PE vs Market: HCT is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HCT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: HCT is overvalued based on its PB Ratio (3.6x) compared to the AU Personal Products industry average (2.4x).


Future Growth

How is Holista CollTech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

12.9%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Holista CollTech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Holista CollTech performed over the past 5 years?

-33.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HCT is currently unprofitable.

Growing Profit Margin: HCT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: HCT is unprofitable, and losses have increased over the past 5 years at a rate of 33.3% per year.

Accelerating Growth: Unable to compare HCT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HCT is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (23%).


Return on Equity

High ROE: HCT has a negative Return on Equity (-35.62%), as it is currently unprofitable.


Financial Health

How is Holista CollTech's financial position?


Financial Position Analysis

Short Term Liabilities: HCT's short term assets (A$5.2M) exceed its short term liabilities (A$2.1M).

Long Term Liabilities: HCT's short term assets (A$5.2M) exceed its long term liabilities (A$903.7K).


Debt to Equity History and Analysis

Debt Level: HCT's debt to equity ratio (17.6%) is considered satisfactory.

Reducing Debt: HCT's debt to equity ratio has reduced from 27.9% to 17.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HCT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: HCT has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 39.7% each year.


Dividend

What is Holista CollTech current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HCT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HCT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HCT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HCT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HCT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.7yrs

Average management tenure


CEO

Rajen Manickavasagar

12.25yrs

Tenure

AU$369,146

Compensation

Dr. Rajendran Manickavasagar A/L V. Marnickavasagar, also known as Rajen, B Ph.(Hons) has been the Chief Executive Officer of Holista CollTech Limited since July 10, 2009 and serves as its Managing Directo...


CEO Compensation Analysis

Compensation vs Market: Rajen's total compensation ($USD276.72K) is about average for companies of similar size in the Australian market ($USD301.38K).

Compensation vs Earnings: Rajen's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: HCT's management team is considered experienced (4.7 years average tenure).


Board Members

Experienced Board: HCT's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Holista CollTech Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Holista CollTech Limited
  • Ticker: HCT
  • Exchange: ASX
  • Founded: NaN
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: AU$16.246m
  • Shares outstanding: 275.35m
  • Website: https://www.holistaco.com

Location

  • Holista CollTech Limited
  • 283 Rokeby Road
  • Subiaco
  • Western Australia
  • 6008
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:01
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.